CME Group Inc (NASDAQ:CME) insider Hilda Harris Piell sold 714 shares of the business’s stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $129.00, for a total transaction of $92,106.00. Following the transaction, the insider now directly owns 28,844 shares in the company, valued at approximately $3,720,876. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

CME Group Inc (NASDAQ:CME) traded down 1.58% during midday trading on Thursday, reaching $125.74. 1,121,386 shares of the company’s stock were exchanged. The company has a market cap of $42.74 billion, a P/E ratio of 25.67 and a beta of 0.72. CME Group Inc has a 12 month low of $98.95 and a 12 month high of $129.31. The company has a 50 day moving average price of $124.48 and a 200 day moving average price of $121.69.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.03. The firm had revenue of $925 million for the quarter, compared to analysts’ expectations of $931.05 million. CME Group had a return on equity of 8.07% and a net margin of 44.97%. The company’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same quarter last year, the business earned $1.14 EPS. On average, equities analysts anticipate that CME Group Inc will post $4.81 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, September 25th. Shareholders of record on Friday, September 8th will be given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 2.10%. The ex-dividend date is Thursday, September 7th. CME Group’s payout ratio is 53.99%.

TRADEMARK VIOLATION NOTICE: This piece was first published by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/09/07/cme-group-inc-cme-insider-hilda-harris-piell-sells-714-shares.html.

A number of hedge funds have recently bought and sold shares of CME. BlackRock Inc. increased its position in CME Group by 2,172.6% during the 1st quarter. BlackRock Inc. now owns 27,265,611 shares of the financial services provider’s stock worth $3,239,152,000 after buying an additional 26,065,883 shares during the period. Janus Henderson Group PLC increased its position in shares of CME Group by 13,530.7% in the second quarter. Janus Henderson Group PLC now owns 6,150,016 shares of the financial services provider’s stock worth $770,227,000 after purchasing an additional 6,104,897 shares during the period. Edgewood Management LLC increased its position in shares of CME Group by 26.4% in the first quarter. Edgewood Management LLC now owns 7,228,349 shares of the financial services provider’s stock worth $858,728,000 after purchasing an additional 1,511,753 shares during the period. Fiera Capital Corp increased its position in shares of CME Group by 243.9% in the second quarter. Fiera Capital Corp now owns 1,926,918 shares of the financial services provider’s stock worth $241,327,000 after purchasing an additional 1,366,557 shares during the period. Finally, Wells Fargo & Company MN increased its position in shares of CME Group by 25.5% in the second quarter. Wells Fargo & Company MN now owns 4,379,568 shares of the financial services provider’s stock worth $548,496,000 after purchasing an additional 889,217 shares during the period. Hedge funds and other institutional investors own 82.66% of the company’s stock.

A number of equities analysts recently issued reports on the stock. BidaskClub lowered shares of CME Group from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating in a research report on Tuesday, July 11th. Keefe, Bruyette & Woods reaffirmed a “hold” rating and set a $127.00 target price on shares of CME Group in a research report on Friday, July 14th. UBS AG reaffirmed a “buy” rating and set a $134.00 target price (down previously from $136.00) on shares of CME Group in a research report on Monday, June 5th. Finally, Royal Bank Of Canada boosted their target price on shares of CME Group from $130.00 to $135.00 and gave the stock an “outperform” rating in a research report on Tuesday, June 20th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating to the company. The company has an average rating of “Hold” and a consensus target price of $131.75.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.